Back
Pieris Pharmaceuticals Quote, Financials, Valuation and Earnings
Sponsored
PIRS
Sponsored
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
31
PIRS
Pieris Pharmaceuticals
Last Price:
16.16
Seasonality Move:
-22.78%
7 Day Trial
ALL ACCESS PASS
$
7
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.Pieris Pharmaceuticals Price Quote
$16.16
-0.40 (-2.42%)
(Updated: September 18, 2024 at 6:55 PM ET)
Pieris Pharmaceuticals Key Stats
Sell
31
Pieris Pharmaceuticals (PIRS)
is a Sell
Day range:
$16.56 - $16.70
52-week range:
$6.20 - $27.20
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.51
P/B ratio:
1.17%
Volume:
2.1K
Avg. volume:
44.8K
1-year change:
-33.65%
Market cap:
$21.9M
Revenue:
$42.8M
EPS:
$-18.71
How Much Does Pieris Pharmaceuticals Make?
Data Unavailable
Is Pieris Pharmaceuticals Growing As A Company?
Data Unavailable
Pieris Pharmaceuticals Stock Price Performance
-
Did Pieris Pharmaceuticals Stock Go Up Last Month?
Pieris Pharmaceuticals share price went down by -0.36% last month -
Did PIRS's Share Price Rise Over The Last Year?
PIRS share price fell by -33.65% over the past 1 year
What Is Pieris Pharmaceuticals 52-Week High & Low?
-
What Is Pieris Pharmaceuticals’s 52-Week High Share Price?
Pieris Pharmaceuticals has traded as high as $27.20 over the past 52 weeks -
What Is Pieris Pharmaceuticals’s 52-Week Low Share Price?
Pieris Pharmaceuticals has traded as low as $6.20 over the past 52 weeks
Pieris Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Pieris Pharmaceuticals?
-
How Much Debt Does Pieris Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does Pieris Pharmaceuticals Have?
Cash and short term investments quarterly total is $19.7M -
What Is Pieris Pharmaceuticals’s Book Value Per Share?
Book value per share is 14.17
Is Pieris Pharmaceuticals Cash Flow Positive?
-
What Is PIRS Cash Flow From Operations?
Cash flow from operations (TTM) is -$37.9M -
What Is Pieris Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $0 -
What Is Pieris Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is $12.6M
Pieris Pharmaceuticals Return On Invested Capital
Data Unavailable
Pieris Pharmaceuticals Earnings Date & Stock Price
-
What Is Pieris Pharmaceuticals's Stock Price Today?
A single share of PIRS can be purchased today for 16.56 -
What Is Pieris Pharmaceuticals’s Stock Symbol?
Pieris Pharmaceuticals trades on the nasdaq under the ticker symbol: PIRS -
When Is Pieris Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Pieris Pharmaceuticals is scheduled on November 14, 2024 -
When Is PIRS's next ex-dividend date?
Pieris Pharmaceuticals's next ex-dividend date is September 19, 2024 -
How To Buy Pieris Pharmaceuticals Stock?
You can buy Pieris Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Pieris Pharmaceuticals Competitors
-
Who Are Pieris Pharmaceuticals's Competitors?
Below is a list of companies who compete with Pieris Pharmaceuticals or are related in some way:
Pieris Pharmaceuticals Dividend Yield
-
What Is PIRS Dividend Yield?
Pieris Pharmaceuticals’s dividend yield currently is 0% -
What Is Pieris Pharmaceuticals’s Payout Ratio?
Pieris Pharmaceuticals’s payout ratio is 0% -
When Did Pieris Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is September 19, 2024 -
What Is Pieris Pharmaceuticals’s Dividend Per Share?
Pieris Pharmaceuticals pays a dividend of $0.00 per share
Pieris Pharmaceuticals Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 0% |
Revenue: | 0% | 152.07% |
Analyst Recommendations
Buy Recommendations: | 0 |
---|---|
Hold Recommendations: | 1 |
Sell Recommendations: | 0 |
Price Target: | 560.00 |
Upside from Last Price: | 3281.64% |